GO
Loading...

Johnson & Johnson

More

  • The Senate Judiciary Committee's nine-member antitrust panel will meet on Wednesday to consider the decisions by Alcon, owned by Novartis AG; Bausch+ Lomb, owned by Valeant Pharmaceuticals; and Johnson& Johnson to put in place minimum sale prices for some of their products.

  • Final Glance: Pharmaceuticals companies Monday, 28 Jul 2014 | 6:04 PM ET

    Baxter International Inc. fell$. 18 or. 2 percent, to $76.47. Bristol-Myers Squibb Co. rose$. 41 or. 8 percent, to $49.80. Hospira rose$. 12 or. 2 percent, to $51.84.

  • Final Glance: Medical Devices companies Monday, 28 Jul 2014 | 6:04 PM ET

    Allergan rose$. 09 or. 1 percent, to $170.15. Boston Scientific Corp. fell$. 14 or 1.1 percent, to $12.97. Medtronic fell$. 14 or. 2 percent, to $62.76.

  • Midday Glance: Medical Devices companies Monday, 28 Jul 2014 | 1:31 PM ET

    Allergan fell$. 02 or percent, to $170.04. Baxter International Inc. fell$. 28 or. 4 percent, to $76.38. Boston Scientific Corp. fell$. 20 or 1.5 percent, to $12.91.

  • Midday Glance: Pharmaceuticals companies Monday, 28 Jul 2014 | 1:31 PM ET

    Baxter International Inc. fell$. 28 or. 4 percent, to $76.38. Bristol-Myers Squibb Co. rose$. 02 or percent, to $49.41. Hospira rose $1.03 or 2.0 percent, to $52.75.

  • Early Glance: Medical Devices companies Monday, 28 Jul 2014 | 10:33 AM ET

    Allergan rose$. 55 or. 3 percent, to $170.61. Baxter International Inc. fell$. 10 or. 1 percent, to $76.55. Boston Scientific Corp. fell$. 14 or 1.1 percent, to $12.97.

  • Early Glance: Pharmaceuticals companies Monday, 28 Jul 2014 | 10:33 AM ET

    Baxter International Inc. fell$. 10 or. 1 percent, to $76.55. Bristol-Myers Squibb Co. fell$. 21 or. 4 percent, to $49.18. Hospira rose $2.43 or 4.7 percent, to $54.15.

  • Europe backs new leukemia drugs from J&J and Gilead Friday, 25 Jul 2014 | 7:20 AM ET

    LONDON, July 25- Two new leukemia drugs from Johnson& Johnson and Gilead Sciences have been recommended for approval by European regulators, paving the way for formal approval in a couple of months. The European Medicines Agency said on Friday its experts had issued positive opinions for J&J's ibrutinib, developed with Pharmacyclics, and Gilead's idelalisib.

  • Final Glance: Medical Devices companies Thursday, 24 Jul 2014 | 6:22 PM ET

    Allergan fell $1.86 or 1.1 percent, to $170.57. Baxter International Inc. rose$. 16 or. 2 percent, to $77.00. Boston Scientific Corp. rose$. 24 or 1.8 percent, to $13.26.

  • Final Glance: Pharmaceuticals companies Thursday, 24 Jul 2014 | 6:22 PM ET

    Baxter International Inc. rose$. 16 or. 2 percent, to $77.00. Bristol-Myers Squibb Co. rose$. 14 or. 3 percent, to $49.46. Hospira rose $1.16 or 2.3 percent, to $51.82.

  • Midday Glance: Pharmaceuticals companies Thursday, 24 Jul 2014 | 1:23 PM ET

    Baxter International Inc. rose$. 20 or. 3 percent, to $77.04. Bristol-Myers Squibb Co. rose$. 20 or. 4 percent, to $49.52. Hospira rose$. 74 or 1.5 percent, to $51.40.

  • Midday Glance: Medical Devices companies Thursday, 24 Jul 2014 | 1:23 PM ET

    Allergan fell$. 78 or. 5 percent, to $171.65. Baxter International Inc. rose$. 20 or. 3 percent, to $77.04. Boston Scientific Corp. rose$. 09 or. 7 percent, to $13.11.

  • Early Glance: Pharmaceuticals companies Thursday, 24 Jul 2014 | 11:37 AM ET

    Baxter International Inc. fell$. 13 or. 2 percent, to $76.71. Bristol-Myers Squibb Co. fell$. 16 or. 3 percent, to $49.16. Hospira rose$. 03 or. 1 percent, to $50.69.

  • Early Glance: Medical Devices companies Thursday, 24 Jul 2014 | 11:37 AM ET

    Allergan fell $1.51 or. 9 percent, to $170.92. Baxter International Inc. fell$. 13 or. 2 percent, to $76.71. Boston Scientific Corp. rose$. 02 or. 2 percent, to $13.04.

  • Final Glance: Medical Devices companies Tuesday, 22 Jul 2014 | 6:02 PM ET

    Allergan fell$. 71 or. 4 percent, to $170.43. Boston Scientific Corp. rose$. 30 or 2.4 percent, to $12.85. Medtronic rose$. 30 or. 5 percent, to $62.71.

  • Final Glance: Pharmaceuticals companies Tuesday, 22 Jul 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 76 or 1.0 percent, to $76.87. Bristol-Myers Squibb Co. rose$. 20 or. 4 percent, to $49.12. Hospira rose$. 31 or. 6 percent, to $50.78.

  • Midday Glance: Pharmaceuticals companies Tuesday, 22 Jul 2014 | 1:57 PM ET

    Baxter International Inc. rose$. 93 or 1.2 percent, to $77.04. Bristol-Myers Squibb Co. rose$. 41 or. 8 percent, to $49.33. Hospira rose$. 27 or. 5 percent, to $50.74.

  • Early Glance: Medical Devices companies Tuesday, 22 Jul 2014 | 11:16 AM ET

    Allergan rose $1.04 or. 6 percent, to $172.18. Baxter International Inc. rose$. 55 or. 7 percent, to $76.66. Boston Scientific Corp. rose$. 23 or 1.8 percent, to $12.78.

  • J&J buying back $5 billion worth of its shares Monday, 21 Jul 2014 | 6:17 PM ET

    NEW BRUNSWICK, N.J.— Johnson& Johnson, the world's biggest maker of health care products, plans to buy back up to $5 billion of the company's common stock. Johnson& Johnson's shares have risen strongly over the past two years, from about $68 to a July 7 all-time closing high of $106.47.

  • July 18- Advertising company Interpublic Group of Cos Inc reported better-than-expected quarterly revenue, boosted by strong growth in the UK and higher ad spending in its core U.S. market. Interpublic's clients include General Motors, Unilever and Johnson& Johnson.